EBRT and High Dose–Rate Brachytherapy for Intermediate- and High-Risk Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
International Journal of Radiation Oncology, Biology, Physics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
External Beam Radiotherapy (EBRT) and High-Dose Rate (HDR) Brachytherapy for Intermediate and High-Risk Prostate Cancer: The Impact of EBRT Volume
Int. J. Radiat. Oncol. Biol. Phys 2019 Oct 11;[EPub Ahead of Print], H Tharmalingam, Y Tsang, A Choudhury, R Alonzi, J Wylie, I Ahmed, A Henry, C Heath, PJ HoskinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.